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Cancer metastasis, the leading cause of cancer-related deaths, is facilitated in part by
the hematogenous transport of circulating tumor cells (CTCs) through the vasculature.
Clinical studies have demonstrated that CTCs circulate in the blood of patients with
metastatic disease across the major types of carcinomas, and that the number of CTCs in
peripheral blood is correlated with overall survival in metastatic breast, colorectal, and
prostate cancer. While the potential to monitor metastasis through CTC enumeration
exists, the basic physical features of CTCs remain ill defined and moreover, the
corresponding clinical utility of these physical parameters is unknown. To elucidate the
basic physical features of CTCs we present a label-free imaging technique utilizing
differential interference contrast (DIC) microscopy to measure cell volume and to quantify
sub-cellular mass-density variations as well as the size of subcellular constituents
from mass-density spatial correlations. DIC measurements were carried out on CTCs
identified in a breast cancer patient using the high-definition (HD) CTC detection assay.
We compared the biophysical features of HD-CTC to normal blood cell subpopulations
including leukocytes, platelets (PLT), and red blood cells (RBCs). HD-CTCs were found to
possess larger volumes, decreased mass-density fluctuations, and shorter-range spatial
density correlations in comparison to leukocytes. Our results suggest that HD-CTCs
exhibit biophysical signatures that might be used to potentially aid in their detection and
to monitor responses to treatment in a label-free fashion. The biophysical parameters
reported here can be incorporated into computational models of CTC-vascular interactions
and in vitro flow models to better understand metastasis.
Keywords: circulating tumor cells, breast cancer, differential interference contrast microscopy, cellular volume,
cellular density
INTRODUCTION
Cancer metastasis, the leading cause of cancer-related deaths, is
facilitated in part by the hematogenous transport of circulat-
ing tumor cells (CTCs) from the primary tumor site to distant
organs. Though CTCs circulate in exceedingly small quantities,
approximately 1 CTC per 109 blood cells, clinical studies have
demonstrated that CTCs circulate in the blood of patients with
metastatic disease across all major types of carcinomas (Allard
et al., 2004), and that the number of CTCs in peripheral blood is
correlated with overall survival in metastatic breast (Cristofanilli
et al., 2004), colorectal (Cohen et al., 2008) prostate (Scher et al.,
2009) and non-small cell lung (Nieva et al., 2012) cancer, while
case reports suggest that CTCs possess morphological features
present in corresponding primary and/or metastatic lesions in
breast (Marrinucci et al., 2007), colorectal (Marrinucci et al.,
2009a), and lung (Marrinucci et al., 2009b) cancer. Together, these
studies indicate that CTCs can be used to survey primary and
metastatic lesions through minimally-invasive peripheral blood
draws.
To date, label-based microscopy techniques have been instru-
mental in identifying CTCs and characterizing the CTC pheno-
type. Putative CTCs in existing purification assays are typically
identified using immunofluorescent antibody labels to epithe-
lial (EpCAM, CK) and leukocyte (CD45) cell surface markers
as well as fluorescent nuclear (DAPI) staining to differentiate
CTCs and leukocytes based on fluorescence expression profiles:
CD45−CK+DAPI+ (CTC) vs. CD45+CK−DAPI+ (leukocyte)
(Racila et al., 1998; Vona et al., 2000; Krivacic et al., 2004; Hsieha
et al., 2006; Nagrath et al., 2007). The combined use of fluorescent
antibodies to cell surface markers and bright field microscopy
based stains (Papanicolau, Wright-Giemsa), for labeling of the
nuclear and cytoplasmic cellular compartments, has been central
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in establishing the pleomorphic similarity of CTCs to their cor-
responding primary and/or metastatic lesions (Marrinucci et al.,
2007, 2009a,b). While there is great potential to monitor metas-
tasis through CTC enumeration and qualitative investigations
of their morphology using these label-based methods, the basic
physical features (e.g., mass, volume, density, density fluctua-
tions), discernable through label-free optical methods, of CTCs
remain ill defined. Moreover, the corresponding clinical utility of
these physical parameters is unknown.
To elucidate the basic physical features of CTCs we developed a
label-free microscopy technique utilizing differential interference
contrast (DIC) to quantitatively elucidate cell volume, sub-cellular
mass-density variations, and the average size of subcellular con-
stituents inferred from spatial mass density correlations. We
report volume, mass density fluctuations, denoted σA[−], and
mass density spatial correlations, denoted LC [μm], for CTCs
isolated from a metastatic breast cancer patient using the HD-
CTC assay (Marrinucci et al., 2012). The physical properties of
HD-CTCs are compared across the normal cellular constituents
of blood: platelets (PLT), red blood cells (RBCs), and leukocytes.
MATERIALS ANDMETHODS
HD-CTC AND LEUKOCYTE IDENTIFICATION AND CHARACTERIZATION
A 54-year-old breast cancer patient provided informed consent
at Scripps Clinic (La Jolla, CA) as approved by the Institutional
Review Board. The patient presented in October 2007 with bilat-
eral invasive ductal mammary carcinoma and biopsy-proven
metastatic disease to bone. The right breast was ER/PR+/
HER-2−, while the left breast was ER/PR/HER-2+ with a posi-
tive axillary node by fine needle aspiration. A bony site biopsy was
ER+, PR−, and HER-2+, all by immunohistochemistry. Blood
was taken prior to a bilateral mastectomy in March 2010.
At each draw, 8mL of peripheral blood was collected in a
rare cell blood collection tube (Streck, Omaha, NE) and pro-
cessed within 24 h after phlebotomy. CTCs were identified using
the HD-CTCmethod, the sensitivity, and specificity of which has
been previously reported in Marrinucci et al. (2012). Briefly, the
HD-CTC isolation and characterization technique consists of a
RBC lysis, after which nucleated cells are attached as a monolayer
to custom-made glass slides. Slides are subsequently incubated
with antibodies against cytokeratins (CK) 1, 4–8, 10, 13, 18, and
19; and CD45 with Alexa 647-conjugated secondary antibody,
nuclei were counterstained with DAPI. For HD-CTC identifi-
cation, an automated digital fluorescence microscopy technique
was used to identify putative HD-CTCs. Fluorescence images of
CTC candidates were then presented to a hematopathologist-
trained technical analyst for interpretation. Cells are classified as
HD-CTCs if they are CK-positive, CD45-negative, contained an
intact DAPI nucleus without identifiable apoptotic changes or
a disrupted appearance and were morphologically distinct from
surrounding leukocytes. Leukocytes were classified according to a
CK-negatiave, CD45-positive, DAPI-positive fluorescence status.
Cartesian coordinates for each HD-CTC on a slide are gener-
ated from a fixed fiduciary marking and used to relocate the
cells of interest for DIC measurements. Leukocytes located in the
same field of view of HD-CTCs were selected at random to be
quantitatively compared to the HD-CTC population.
PREPARATION OF HUMAN PLATELETS
Human venous blood was drawn from healthy donors into
citrate-phosphate-dextrose (1:7 vol/vol). PLT rich plasma (PRP)
was prepared by centrifugation of anticoagulated blood at
200 g for 10min. PLTs were further purified from PRP
by centrifugation at 1000 g in the presence of prostacy-
clin (0.1μg/mL). Purified PLTs were resuspended in modi-
fied HEPES/Tyrode buffer (129mM NaCl, 0.34mM Na2HPO4,
2.9mM KCl, 12mM NaHCO3, 20mM HEPES, 5mM glu-
cose, 1mM MgCl2; pH 7.3) containing 0.1μg/mL prostacy-
clin. PLTs were washed once by centrifugation and resuspended
in modified HEPES/tyrode buffer at indicated concentrations.
Purified PLTs were fixed and immobilized on poly-L-lysine coated
coverslips.
OPTICAL MEASUREMENT OF CELLULAR VOLUME AND AREA
DIC microscopy is carried out by illuminating the sample of
interest with orthogonally polarized co-propagating wave fronts
separated by a distance approximately equal to half the wave-
length of the light source. These distinct wave fronts are generated
by a Wollaston prism in combination with a polarizer placed
in the illumination optics of the microscope. Image contrast is
produced by specimen mass density variations that give rise to
relative phase distortions in the transmitted orthogonally polar-
ized wave fronts exiting the sample. A second Wollason prism
and polarizer are used to carry out polarization-dependent com-
mon path interferometry; to interfere the exiting orthogonally
polarized fronts from the diffraction limited imaging volume
of the objective lens. This process converts sample induced
phase perturbations in the orthogonal polarization modes into
a detectable intensity (Preza et al., 2011). High numerical
aperture (NA = 0.9) Köhler illumination enables the visualiza-
tion of distinct transverse planes of the specimen along the
optical axis.
HD-CTCs were relocated and through-focus DIC imagery
at ×63 magnification, NA = 1.4, of each cell type was per-
formed on a Zeiss Axio Imager 2 microscope (Carl Zeiss
MicroImaging GmbH, Germany) under software control by
SlideBook (Intelligent Imaging Innovations, Denver, CO),
Figures 1A,B. Images were post-processed using a custom pro-
gram written in MATLAB (The MathWorks, Inc., USA). Post-
processing consisted of the application of a Hilbert transform
to each en face DIC image to ensure optimal contrast in image
cube construction (Arinson et al., 2000), Figure 1C. This process
enables thresholding of DIC images at the cost of introducing
image blur along the axial direction. Image blur is eliminated
using a high-pass filter applied to each cross-sectional image of
the image cube, Figure 1D.
The cross sectional areas of the cell in distinct sagittal planes
separated by 0.5 [μm] were added together to obtain cellular
volume. Each voxel in the analysis corresponds to a diffrac-
tion limited volume of 0.28 [μm] × 0.28 [μm] × 0.35 [μm]
= 0.029 [fL]. No thresholding of the high-pass filtered Hilbert
transformed sagittal images was required. Further details on the
method and validation of the Hilbert DICmethod for volume are
reported in Baker et al. (2012). Cellular area was determined by
outlining each cell in en face DIC images.
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FIGURE 1 | Image segmentation of DIC image cubes. (A) En face DIC
image, leukocyte, (B) corresponding cross sectional image through center
of cell, (C) Hilbert transform of (B), (D) high pass filter applied to (C).
THE DIC IMAGE CONTRAST ARISES FROM SUB-CELLULAR DENSITY
GRADIENTS ALONG THE SHEAR DIRECTION OF THE
WOLLASTON PRISMS
Following (Preza et al., 1999) we demonstrate that the DIC con-
trast is dominated by mass-density gradients inside the focal vol-
ume of the objective lens. This provides the rationale to adapt the
language of “mass density variations” as opposed to “pathlength
changes” in describing the origin of DIC image contrast.
We begin with Equation 20 of Preza et al. (1999); a three
dimensional DIC imaging model that presumes temporal coher-
ence of the waves interacting with the sample. The temporal
coherence assumption is appropriate as the coherence length of
the mercury lamp is on the order of cm while the thickness of the
sample times the refractive index is on the order of μm. To deter-
mine the form of the fields interfering at the detector plane the
amplitudes of the waves must be added together.
Referring to Figure 7 of Preza et al. (1999) we define our
notation: Let A denote the area of the front focal plane of the
condenser lens,
−→
ξ denote a point in the front focal plane of the
condenser lens, s(
−→
ξ ) denotes the intensity of the light source in
the focal plane of the of the condenser lens. x, y, z are coordinates
in the image plane; x′, y′, z′ are coordinates in the object plane.
The transmitted field of the specimen is denoted as f
(
x, y, z
)
. The
point spread function (PSF) of the DIC microscope is denoted
h
(
x − x′, y − y′, z − z′). Lastly, the Köhler illumination plane
wave fields are denoted Uk(
−→
ξ, x, y); see the definition of these
waves just after Equation 3 of Preza et al. (1999).
The three dimensional DIC imaging model is Equation 20 of
Preza et al. (1999).
i
(
x, y, z
) =∫
A
s(
−→
ξ )
∣∣∣∣∫
R3
f
(
x′, y′, z′
)
h
(
x−x′, y−y′, z − z′)
Uk(
−→
ξ , x′, y′)dz′dx′dy′
∣∣∣2d−→ξ (1)
We make the following simplifying assumptions:
1. We assume the DIC PSF is a delta function in x and y coor-
dinates but we retain broadening along the optical axis. The
DIC PSF is given in Equation 1 of Preza et al. (1999). The axial
PSF is denoted P(z − z′). θ is the bias retardation introduced
by the translation of the Wollaston prism. x is the lateral
shear introduced by the Wollaston prism. The DIC PSF is
then
h
(
x − x′, y − y′, z − z′) = (1
2
e−iθδ
(
x − x′ − x, y)
− 1
2
eiθδ
(
x − x′ + x, y))P (z − z′) (2)
2. The specimen is a “phase” object. The transmitted field is of
the form
f
(
x′, y′, z′
) = exp (−iφ (x′, y′, z′)) (3)
Plugging in Equation 2 and 3 into Equation 1, we carry out the
integration in the x′, y′ variables to obtain:
i
(
x, y, z
) = 1
4
∫
A
s(
−→
ξ )
∣∣∣∣∫
R
P
(
z − z′) {U−k e−iφ−−iθ
− U+k e−iφ
++iθ} dz′∣∣∣2d−→ξ (4)
In this expression we have utilized a shorthand notation in which
U±k = Uk(
−→
ξ , x ± x, y, z′), and φ± = φ(x ± x, y, z′).
We next linearize the phase terms in Equation 4 by tak-
ing the small angle approximation of the complex exponentials;
appropriate for weak index contrast specimens.
i
(
x, y, z
) = 1
4
∫
A
s(
−→
ξ )
∣∣∣∣∫
R
P
(
z − z′) {(U−k − U+k )
+ i(φ+U+k − φ−U−k ) − iθ(U−k + U+k )
}
dz′
∣∣∣2d−→ξ
(5)
Next, we assume that for fixed
−→
ξ that Uk ≈ U−k ,Uk ≈
U+k , as these fields are separated along the shear direc-
tion by approximately λ/2. This enables the simplification of
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Equation 5 to:
i
(
x, y, z
) = 1
4
∫
A
s(
−→
ξ )
∣∣∣∣∫
R
P
(
z − z′)
{
(φ+ − φ− − 2θ)Uk
}
dz′
∣∣∣∣2d−→ξ (6)
Multiplying and dividing the phase difference by the magnitude
of the shear, x = s we obtain:
i
(
x, y, z
) = 1
4
∫
A
s(
−→
ξ )
∣∣∣∣Uk ∫
R
P
(
z − z′)
{
(sxˆ · ∇φ − 2θ)} dz′∣∣∣∣2 d−→ξ (7)
We now develop an expression for the phase in terms of the mass-
density of the sample.
Let −→p (z′,−→ξ ) denote the parameterized path of the wave. We
utilize the variable dependence of the Kohler waves on
−→
ξ as
described in Figure 7 of Preza et al. (1999).We presume that waves
traverse the sample in straight-line trajectories—an assumption
that is appropriate to weak index contrast samples such as cells.
Let fc denote the focal length of the condenser lens.
−→p (z′,−→ξ ) = z′
⎛⎝ξx
fc
√
1 − ξ
2
y
f 2c
xˆ + ξxξy
f 2c
yˆ +
√
1 − ξ
2
x
f 2c
zˆ
⎞⎠ = z′ ξ̂
(8)
Letting k denote the wave number, φ the phase of waves travers-
ing a specimen, and n the refractive index of the sample, under
the paraxial approximation for weak index contrast specimens the
phase of plane waves traversing the sample is given by:
φ
(−→p (z′,−→ξ )) = k ∫ z′
0
n
(−→p (z′′,−→ξ )) dz′′. (9)
The refractive index, as shown in Barer (1952) is related to the
mass-density, denoted C [pg/fL], according to:
n
(
x, y, z
) = no + αC (x, y, z). (10)
Where no is the background index of the cell within a diffraction
limited volume, α is the refractive increment ∼ 0.2 [fl/pg]. We
substitute Equation 10 into Equation 9 and then substitute the
resulting expression into Equation 7 to obtain:
i(x, y, z) = 1
4
∫
A
s(
−→
ξ )
∣∣∣∣∣Ukαksxˆ · ∇
∫
R
P
(
z − z′) ∫ z′
0
C
(
z′′ ξ̂
)
dz′′
dz′ − 2θUk
∫
R
P
(
z − z′) dz′∣∣∣∣2d−→ξ . (11)
Lastly, we note that the PSF limits the axial contributions of the
mass density to axial locations near the focal position given by z.
Without loss of generality, we presume an axial PSF with a square
function shape with width 2z about the focal point z. We find
that:∫
R
P
(
z − z′) ∫ z′
0
C
(
z′′ ξ̂
)
dz′′dz′ ≈
∫ z+z
z−z
C
(
z′′ ξ̂
)
dz′′.(12)
Substituting Equation 12 into Equation 11 we arrive at the main
result
i(x, y, z) = 1
4
∫
A
s(
−→
ξ )
∣∣∣∣Ukαks ∫ z+z
z−z
xˆ · ∇C (z′′ ξ̂ ) dz′′
− 4θzUk
∣∣∣∣2 d−→ξ . (13)
This formula demonstrates that the DIC intensity contrast at a
particular z location inside the sample is dominated by the spatial
gradient of the concentration of cellular mass in that plane (the
integral over dz′′).
The “pathlength” point of view of DIC microscopy—while
entirely valid—does not speak to the main contribution of con-
trast inside the cell. The axial distance over which the phase is
being compared (the limits of integration of the axial variable
z′′) among the sheared trajectories is held fixed by the objective
lens. Hence the height of the sample has been decoupled from the
refractive index due to optical sectioning by the objective lens.
This point of view breaks down when the axial extent of the
sample changes inside the focal volume: a situation that might
arise as the focal volume first encounters the top of the cell.
OPTICAL DETERMINATION OF SUB-CELLULAR DENSITY
FLUCTUATION AND SPATIAL CORRELATION
The DIC intensity is a non-linear function of the mass den-
sity gradient of the sample along the shear direction of the
Wollaston prisms (Preza et al., 2011). Furthermore, the DIC
intensity depends on the bias settings of theWollaston prisms and
illumination conditions (Preza et al., 2011). These complications
often limit the use of DICmicroscopy to qualitative investigations
of morphology as the DIC intensity is difficult to relate to physical
properties (e.g., density) of the sample. DIC microscopy images
do, however, have a simple physical interpretation: they visualize
edges of sub-cellular features. The variations of the DIC intensity
in space can then be utilized, by analogy with time series analysis
of random processes (Wainstein and Zubakov, 1962; Ishimaru,
1978; Subramanian et al., 2009), to quantify the average size
of sub-cellular constituents, through spatial correlation, and the
average magnitude of density fluctuations, through the analysis
of DIC intensity amplitude variations. This heuristic analysis is
able to probe the organization of cellular features ranging from
the diffraction limit up to multiple microns in scale.
For each pixel location (x, y) in the image of a cell (Figure 2A),
the axial profile of the DIC intensity was recorded using a charge
coupled device camera (CCD), (Figure 2B). The DIC signal was
then normalized by the background glass signal to eliminate
the effects of exposure time and gain settings (Figure 2C). A
smooth fit to the normalized DIC axial profile was then per-
formed, (Figure 2C), and subtracted from the normalized DIC
intensity to determine the fluctuating part of the DIC axial profile,
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FIGURE 2 | Fluctuation and spatial correlation analysis of axial DIC
intensity profiles. (A) En face DIC image CTC. (B) Axial profiles of DIC
intensity for pixels in the cell (black) and glass substrate (blue), (C) normalized
DIC intensity profile (black, cell signal divided by glass signal) for pixels inside
the cell and corresponding smooth fit (blue), (D) fluctuating part of the DIC
intensity (normalized signal minus smooth fit), (E) autocorrelation function of
the fluctuating part of the DIC signal, the correlation length Lc [μm] is defined
as the first zero crossing, (F) histogram of the fluctuating part of the DIC
intensity, the mass-density fluctuations are quantified through the standard
deviation, σA[−], of the histogram.
(Figure 2D). The autocorrelation of the fluctuating part of the
DIC signal was then numerically computed, (Figure 2E). The cor-
relation length, LC [μm], for each axial profile within a cell was
defined as the first zero-crossing of the autocorrelation function.
The average magnitude of sub-cellular density fluctuations was
assessed by binning the fluctuating part of the DIC intensity into
a histogram, (Figure 2F). The standard deviation of the fluctua-
tions, σA[−], was determined and recorded for each pixel location
within the cell. Example LC and σA maps are presented for CTCs
and leukocytes in Figures 4C,D, respectively.
STATISTICAL ANALYSIS
The Jarque–Bera test was used to evaluate normality of all param-
eters. One-Way analysis of variance with Bonferonni post-hoc
analysis was used to assess statistical significance among param-
eters across multiple normally distributed cell parameters. The
Kruskal–Wallis test was used to assess significance among non-
normally distributed parameters. P-values of 0.05 or less were
considered significant. All quantities presented as mean ± stan-
dard deviation unless otherwise noted.
RESULTS
BREAST CANCER ASSOCIATED HD-CTCs HAVE LARGER
VOLUMES AND AREAS THAN NORMAL BLOOD CELL
SUBPOPULATIONS
To investigate the validity of the optical volume measurement
technique, we performed measurements on polystyrene spheres
and found the measured volumes to coincide with the manufac-
turers specifications (Baker et al., 2012). To establish the ability
of the technique to work with biological specimens, we purified
populations of PLTs (N = 30) and RBCs (N = 20) from healthy
volunteers. PLTs and RBCs were measured to have volumes
(mean ± standard error of the mean) of 10.5 ± 0.5 fL, 100.6 ±
4.0 fL, within physiological norms determined by the Coulter
method (Paulus, 1975; Lichtman, 2005). See Table 1.
After this initial validation of the technique, we set out to
determine if HD-CTCs had distinct volumes from leukocytes. We
measured the volumes of HD-CTCs (N = 42, using four slides
from the different blood draws of one patient) and leukocytes
(N = 100) identified in the peripheral blood of a breast can-
cer patient with known metastatic disease, (Figure 3). Leukocytes
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Table 1 | Biophysical properties of normal peripheral blood cells and breast cancer associated HD-CTCs.
Cell type Area [μm2] Volume [fL] LC [μm] σA[−] N
PLT 7.5 ± 0.3 10.5 ± 0.5 0.42 ± 0.03 0.06 ± 0.01 30
RBC 42.0 ± 1.0 100.6 ± 4.0 1.19 ± 0.05 0.06 ± 0.01 20
Leukocyte 48.0 ± 0.6 234.1 ± 4.1 0.87 ± 0.03 0.17 ± 0.05 100
HD-CTC 135.6 ± 6.0* 851.6 ± 45.8* 0.80 ± 0.04* 0.12 ± 0.04* 42
*Denotes p < 0.001 with respect to leukocytes. Leukocytes and HD-CTCs are from the same patient while PLTs and RBCs were collected from healthy donors.
FIGURE 3 | En face and cross sectional post-processed DIC images of
normal blood cell populations and HD-CTCs. Representative en face and
sagittal Hilbert transformed DIC images of (A,B) PLT, (C,D) RBC, (E,F)
leukocytes. (G) Merged fluorescence image of HD-CTCs and leukocytes
from breast cancer patient, (H) corresponding DIC image, (I) corresponding
Hilbert transformed DIC image, (J) corresponding cross sectional images at
the t, top; m, middle; b, bottom locations denoted in (I). (K) Scatter plot of
cell areas vs. corresponding volume for each cell type.
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were chosen at random in the field of view containing the HD-
CTC. HD-CTCs were determined to have significantly larger
volumes (mean ± standard error of the mean), 851.6 ± 45.8 [fL],
than leukocytes, 234.1 ± 4.1 fL, p < 0.0001 (Table 1).
Next, we measured the area of each cell type to test for overlap
of this parameter among HD-CTCs and leukocytes as previ-
ously observed in colorectal cancer (Marrinucci et al., 2009a)
and prostate cancer (Stott et al., 2010). The area for normal cell
types was measured to be 7.5 ± 0.3 [μm2] (PLT), 42.0 ± 1.0
[μm2] (RBC), 48.0 ± 0.6 [μm2] (leukocytes). CTCs were found
to have a mean area of 135.1 ± 6.0 [μm2], significantly larger
than leukocytes, p < 0.0001 (Table 1).
HD-CTCs EXHIBIT SMALLER MASS-DENSITY FLUCTUATIONS
AND SHORTER-RANGE MASS-DENSITY SPATIAL
CORRELATIONS IN COMPARISON TO LEUKOCYTES
Previously, we determined by Wright-Giemsa staining that CTCs
have a high degree of pleomorphism, exhibit a range of high
and low nuclear-to-cytoplasmic ratios, and possess morpholog-
ical features similar to the primary and/or metastatic lesions in
breast (Marrinucci et al., 2007), colorectal (Marrinucci et al.,
2009a), and lung (Marrinucci et al., 2009b) cancer.
As the organization of cellular mass density is central in deter-
mining the absorption properties exhibited by stained cells and
thus central to the qualitative evaluation of CTCs by patholo-
gists, we sought to quantify the heterogeneity of sub-cellular mass
density using the optical sectioning and edge detection capabili-
ties of DICmicroscopy. DIC intensity variations along the optical
axis were used to infer the relative magnitude of sub-cellular den-
sity fluctuations, σA[−], and spatial correlations along the axial
direction can be used to assess the average size of sub-cellular
constituents, LC [μm].
First, we established the utility of the (σA, LC) parameters
in distinguishing purified populations of normal blood cells,
(Figures 5B,C). LC was found to be unique to each blood cell
type: 0.42 ± 0.03 [μm] (PLT), 1.19 ± 0.05 [μm] (RBC), 0.87 ±
0.03 [μm] (leukocyte), p < 0.001, while σA values were iden-
tical for PLTs and RBCs: 0.06 ± 0.01 [−], though distinct for
leukocytes: 0.17 ± 0.05 [−], p < 0.001, (Table 1).
Next, we explored the (σA, LC) properties of HD-CTCs and
compared these to leukocytes. Mapping of the σA and LC param-
eters over the nuclear and cytoplasmic compartments of the
cell revealed that CTCs had reduced nuclear density fluctuations
and reduced nuclear spatial correlation lengths in comparison
to leukocytes, (Figures 4C,D). Upon binning the (σA, LC) val-
ues corresponding to each cell type into histograms, systematic
decreases in both of these parameters were observed cell-wide for
CTCs in comparison to leukocytes, (Figures 4F,G). No differences
between HD-CTCs and leukocytes were observed in histograms
of the DIC image alone, (Figure 4E).
To determine the ability of the (σA, LC) parameters to quan-
titatively characterize CTCs and leukocytes, we computed the
mean values of σA and LC for CTCs (N = 42) and compared
these to leukocytes and found statistically significant decreases
in both parameters among HD-CTCs in comparison to leuko-
cytes, (Figure 5, Table 1). The mean subcellular constituent size,
LC , for HD-CTCs was 0.80 ± 0.04 [μm] compared to 0.87 ± 0.03
[μm] for leukocytes, p < 0.001; density fluctuations for HD-
CTCs, σA, were found to be 0.12 ± 0.04 compared to 0.17 ± 0.05
for leukocytes, p < 0.001, Table 1.
DISCUSSION
Clinical studies have demonstrated that metastatic cancer is
accompanied by the presence of CTCs in the peripheral cir-
culation across the major carcinomas (Allard et al., 2004) and
that CTCs possess morphologic similarities to primary and/or
metastatic lesions (Marrinucci et al., 2007, 2009a,b) and are
morphologically distinct from the surrounding white blood cell
population (Marrinucci et al., 2012).
To date, the biophysical characterization of CTCs has been
restricted to two-dimensional investigations of morphology, area,
and nuclear to cytoplasmic ratio. Here we quantified basic
three-dimensional biophysical properties of CTCs associated with
metastatic disease of the breast: volume and mass density varia-
tions. We find that HD-CTCs are characterized by larger volumes,
decreased mass-density fluctuations, and possess shorter-range
spatial density correlations in comparison to leukocytes. We
attribute this basic difference in HD-CTCs and leukocytes to the
high nuclear content of leukocytes, giving rise to increased ampli-
tude fluctuations, and the increased amount of compaction of
nuclear material in leukocytes, giving rise to larger spatial corre-
lations (sub-cellular constituent sizes). These results mirror the
qualitative observation that HD-CTCs in this study had large,
spread out nuclei, that were homogenous in comparison to the
surrounding leukocytes, Figure 4B. Future studies linking DIC
based measurements of mass density variations with nano-scopic
tools (Subramanian et al., 2008) will provide insight into nuclear
architecture over the nano-to-micro scale divide (Zink et al.,
2004).
The optical sectioning capability of DIC microscopy provides
a means to account for structural information that is normally
out of focus or not detectable in fluorescence and stain based
imaging, thus yielding a complementary characterization of CTC
cellular structure. Indeed, we found that in some instances the
cell bodies of CTCs were spread across multiple planes perpen-
dicular to the optical axis, spanning up to 10μm, while the cell
bodies of the leukocyte population were consistently confined to
a 3–4μm range about the central focal plane. As previous reports
(Marrinucci et al., 2009a; Stott et al., 2010) utilizing fluorescence
microscopy have documented the general separation but partial
overlap of CTC area with leukocyte area and the similarity of
nuclear to cytoplasmic ratio among breast cancer associated CTCs
and leukoctyes (Marrinucci et al., 2007) the future measurement
of CTC volume across tumor type and disease stage will provide
further insight into the geometric similarities and differences of
CTCs and the corresponding leukocyte population.
Physical parameters independent of volume and area, such
as density amplitude fluctuations and spatial correlations intro-
duced in this study, provide a complementary measurement of
cellular structure that attempt to quantify the qualitative obser-
vations of pathologists using stain based analysis under light
microscopy. Investigations on transformed human cell lines uti-
lizing label-free optical scattering and spectroscopic reflection
microscopy measurements have demonstrated the presence of
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FIGURE 4 | Fluctuation and spatial correlation maps: comparison
of HD-CTCs and leukocytes. (A) Merged fluorescence image of
HD-CTCs and leukocytes, (B) corresponding DIC images, (C) spatial
correlation length map, (D) density amplitude fluctuation map,
(E) histogram of DIC intensity of cells indicated with white
arrows in (B). (F) HD-CTC and leukocyte Lc histograms of cells indicated
in (C). (G) HD-CTC and leukocyte σA histograms of cells indicated
in (D).
distinct optical signatures from cancer cells: increased sub-cellular
constituent size (Mourant et al., 1998), and an increased amount
of structural “disorder” at the nanoscale (Subramanian et al.,
2008). These observations suggest that cancer at the cellular level
is characterized by unique structural features that can be utilized
to detect, monitor, and potentially understand cancer.
The DICmethod presented is utilized subsequent to molecular
based identification of CTCs using the HD-CTC assay. Future val-
idation studies are required to assess the sensitivity and specificity
of the biophysical metrics in relation to the HD-CTC inclusion
criteria. To be competitive with the HD-CTC assay, the DIC
method would need to be drastically sped up. Currently, the DIC
method requires two minutes to complete image cube acquisition
of a single field using a Zeiss Axio Imager 2 with a moveable stage.
This time could be reduced by a factor of 10 with a piezo-driven
objective lens holder. Post-processing of image cubes in MATLAB
currently takes 5–7min on a Dell TerraStation using the full res-
olution image cubes. Down sampling of the cubes to courser
grids could speed up computation time at the possible expense
of losing information. Future optimization studies are required
to make the label-free DIC method competitive with label-based
approaches.
Probing the “fluid phase” of cancer has been technologi-
cally challenging owing to the minute concentration of CTCs
in the peripheral blood of cancer patients with metastatic dis-
ease. The advent of modern CTC isolation and characterization
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FIGURE 5 | Mass density fluctuation and spatial correlation metrics
for normal blood cell subpopulations and HD-CTCs. (A) Scatter plot of
spatial correlation length vs. amplitude fluctuations for HD-CTCs and
leukocytes from breast cancer patient. (B) Box plot comparing population
averages of the axial resolved DIC amplitude fluctuations averages of the
axial resolved DIC intensity spatial correlation length among PLTs, RBCs,
leukocytes, and HD-CTCs. (C) Box plot comparing population averages of
the axial resolved DIC intensity spatial correlation length among PLTs,
RBCs, leukocytes, and HD-CTCs. *Denotes p < 0.001 in comparison to
leukocytes.
methods has recently enabled the use of these rare cells to
survey primary and metastatic tumors through non-invasive
blood draws. This study suggests that CTCs may possess a dis-
tinct set of physical parameters in comparison to the white
blood cell populations in the same patient. However, these
parameters have yet to be developed completely to demon-
strate their utility for clinical applications. Further studies
will be required across multiple patients and disease types
to determine whether the physical parameters observed in
this study are conserved across patient populations, time,
treatment, and cancer type. Measurement of the basic bio-
physical characteristics of CTCs is critical to both under-
standing the physical characteristics and chemical kinetics
of metastasis and aiding in future detection of CTCs in
non-perturbative ways to maintain the viability of these enig-
matic cells.
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